May 12 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2023 Mar 31, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 6 mln 1 mln 127 mln
(+253.1 pct) (-73.7 pct) (+214.9 pct)
Operating loss 294 mln loss 189 mln loss 830 mln
Recurring loss 289 mln loss 198 mln loss 783 mln
Net loss 290 mln loss 196 mln loss 786 mln
EPS loss 9.61 yen loss 8.01 yen loss 25.56 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T